Synthetic Biologics Reports Results of Independent Third Party Evaluations of Trimesta™ Data from Investigator-Sponsored Phase 2 Clinical Trial for Relapsing-Remitting Multiple Sclerosis
Synthetic Biologics, 2 Feb 2016
Accessed on 9 Feb 2016 from http://www.syntheticbiologics.com/news-media/press-releases/detail/198/synthetic-biologics-reports-results-of-independent-third.